Signatureglobal (India) Limited (SIGNATURE)
Investor Presentation
AI summary
- Q1FY27 sales at INR 19.7 bn, 33% CAGR FY22-FY26; collections INR 6.7 bn
- Average sales realization rose to INR 17,093/sqft in Q1FY27 from INR 15,250/sqft in FY26
- Operating cash surplus before land investment INR 0.3 bn; net debt INR 3.9 bn as of June 2026
- Revenue recognized INR 5.5 bn with 23.7% adjusted gross margin and 6.3% adjusted EBITDA margin
- PAT was negative INR 0.2 bn in Q1FY27; revenue recognition expected to strengthen with project completions
- Strong project pipeline: 9.2 mn sqft ongoing, 23.2 mn sqft recent launches, 17.8 mn sqft forthcoming
- Strategic JV with RMZ Group for 4 mn sqft commercial development on SPR, Gurugram
- Focus on mid-income and affordable housing in NCR with 13% market share in NCR mid-income segment
- Sustainability focus with EDGE/IGBC certifications and GRESB score of 84
- Experienced management team and strong distribution network with 2,600+ channel partners
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SIGNATURE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SIGNATURE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Signatureglobal (India) Limited
Important.
The summary above is generated automatically from Signatureglobal (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.